Why is Venus Remedies falling/rising?

As of 11-Jul, Venus Remedies Ltd is experiencing a decline in its stock price, currently at Rs 459.80, which reflects a decrease of 3.2 points or 0.69%. The stock has been underperforming, having lost 1.92% over the last two days and underperformed its sector by 1.27% today. Despite opening with a gain of 4.97% and reaching an intraday high of Rs 486, it also touched a low of Rs 447.2, indicating high volatility with an intraday fluctuation of 5.39%. In terms of longer-term performance, the stock has shown resilience with a year-to-date return of 45.90% and a 130.13% increase over the last three years, outperforming the Sensex significantly during these periods. The company has also reported strong financials, including a 99.81% growth in net profit and positive results for the last two quarters, which supports its attractive valuation.
In the broader market context, while Venus Remedies has demonstrated strong long-term performance, its recent short-term decline contrasts with the Sensex, which has seen a slight decrease of 1.12% over the past week. The stock's performance relative to the benchmark indicates that while it has been a strong performer historically, current market dynamics and investor sentiment may be affecting its immediate price movement. Additionally, the lack of domestic mutual fund investment could signal caution among institutional investors, potentially impacting the stock's liquidity and price stability.